R. Janssen et al., Analysis of recombinant mycobacteria as T helper type 1 vaccines in an allergy challenge model, IMMUNOLOGY, 102(4), 2001, pp. 441-449
The potential for development of mycobacteria as T helper type 1 (Th1) vacc
ines capable of induction of Th1 responses to recombinant antigens was expl
ored in a model system based on an immunodominant peptide from house dust m
ite. Different recombinant mycobacterial preparations were compared for the
ir ability to induce a Th1 response to the peptide. It was found that mycob
acterial viability was not a prerequisite for Th1 immunogenicity. A dominan
t interferon-gamma (IFN-gamma) response to peptide was observed in splenocy
tes from C57BL/6J mice immunized with live or heat-killed preparations of r
ecombinant Mycobacterium vaccae or with live attenuated bacillus Calmette-G
uerin (BCG) vaccine expressing the antigen. Interleukin-5 (IL-5), a marker
of a Th2 response, was detected only in mice receiving live M. vaccae. A si
milar pattern was observed in BALB/b mice, although the magnitude of the IF
N-gamma response was much lower. Control and immunized mice were subsequent
ly exposed to allergen using a Th2-inducing challenge protocol. A significa
nt shift from a Th2 to a Th1 response was observed in immunized mice, as ju
dged by cytokine expression by splenocytes and by subclass of circulating a
ntibody. The effect was seen in three inbred mouse strains differing in the
ir innate bias towards Th1 or Th2 responses. It was dependent on the presen
ce of specific antigen in the mycobacterial preparation and, under the immu
nization conditions tested, was more pronounced with dead M. vaccae than wi
th live BCG as carrier vaccine. The results demonstrate the potency of kill
ed mycobacteria as Th1 adjuvants and suggest a potential application for re
combinant mycobacteria in antigen-specific immune modulation.